SARS-CoV-2 An gen Rapid Test


ImmoGnost's CE-certified SARS-CoV-2 (COVID-19) rapid test features a high sensitivity of 96.19% and specificity of 99.04% and is the first COVID-19 antigen rapid test to be produced entirely in Germany. This is true not only of the production location, but also of the raw materials used. The ImmoGnost SARS-CoV-2 (COVID-19) Rapid Test is a point-of-care test that must be performed by medically trained personnel. It does not, however, require additional staff to determine the results, nor does it require a corresponding laboratory. The sample is taken from the anterior nasal region. A swab depth of only 2.5 cm is necessary for this. The test result is available in just 10 minutes. Thanks to this, the ImmoGnost SARS-CoV-2 (COVID-19) rapid test immediately provides an initial, daily update on the infection status of the person tested. All the materials needed for the swab are included in the ImmoGnost SARS-CoV-2 (COVID-19) rapid test package. This test is performed with a test tube into

Vorteile des Produkts

  • 96.19% sensitivity and 99.04% specificity
  • Developed, produced (including all raw materials) and certified (CE certificate)
  • German manufacturer with many years of experience in the development and product



Ähnliche Produkte

SARS-CoV-2 An gen Rapid Test


Developed and manufactured in Germany

Healthy Donor Specimens

Corona, COVID, COVID-19, SARS, SARS-CoV-2, Virus

Serum, Plasma, Urine and Faeces from Normal Donors

COVID-19 Specimens

Corona, COVID, COVID-19, PCR, SARS, SARS-CoV-2, Virus

Swabs, Serum, Plasma tested for SARS-CoV-2